Roche has agreed to acquire Sweden-based Saga Diagnostics for $595 million, integrating its molecular residual disease (MRD) testing platform into Roche’s Foundation Medicine unit. The deal aims to ...
Roche has agreed to acquire molecular residual disease (MRD) specialist, Saga Diagnostics and its platform in a $595m bid – further expanding its cancer monitoring portfolio. This merger will see ...
This article first appeared on GuruFocus. Freudenberg Group has stepped into the Nilfisk (NLFKF) story at a moment when the company had been struggling to rewrite its own. The German family-owned firm ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results